Advancing Multiple Myeloma Research Together

Through Clincal research, the TRIlogy program is helping advance our understanding of
multiple myeloma while exploring potential new treatment options for eligible participants.

Advancing Multiple Myeloma Research Together

Through Clincal research, the TRIlogy program is helping advance our understanding of
multiple myeloma while exploring potential new treatment options for eligible participants.

Advancing Multiple Myeloma Research Together

Through Clincal research, the TRIlogy program is helping advance our understanding of
multiple myeloma while exploring potential new treatment options for eligible participants.

Frequently Asked Questions

TRIlogy-5

Business websites

Legal

Get in touch

This site is governed solely by applicable U.S. laws and governmental regulations. Please see our Privacy Policy. Use of this site constitutes your consent to application of such laws and regulations and to our Privacy Policy. Your use of the information on this site is subject to the terms of our Legal Notice.

Advancing Multiple Myeloma Research Together

Advancing Multiple Myeloma Research Together

Advancing Multiple Myeloma Research Together

Frequently Asked Questions

What is a clinical research study?

Are there safety measures for clinical research study participants?

What is an IRB/IEC?

Does participating in a study cost me anything?

Will there be any participant support services?

How will I know if the study is going well?

What happens after the study?

Why might I not qualify for a study?